A Research Dynamo: Avi Schroeder at Technion Israel Institute of Technology
43-year-old Technion research dynamo Avi Schroeder is on a mission—and a “phenomenon” with four startup ventures under his belt, he […]
43-year-old Technion research dynamo Avi Schroeder is on a mission—and a “phenomenon” with four startup ventures under his belt, he […]
Russell P. Rosenberg, PhD, is currently the chief science officer and CEO of NeuroTrials Research, Inc. and the director of […]
Dr. Krop is a clinical translational medical oncologist whose primary research focuses on understanding and overcoming mechanisms of resistance to […]
Recently, BeiGene Ltd’s lymphoma treatment Brukinsa was approved by the U.S. Food and Drug Administration. This is the first time a […]
Dr. Lyudmila Bazhenova, professor of Medicine and thoracic oncologist with the University of California San Diego, and active principal investigator in […]
Ford Health System has named world-renowned neurosurgeon Dr. Steven Kalkanis as Chief Executive Officer of the Henry Ford Medical Group. Dr. […]
Thomas Gajewski, MD, PhD, AbbVie Foundation Professor of Cancer Immunotherapy in the Ben May Department for Cancer Research and Professor […]
With a rapidly aging population, it is as important as ever to conduct Alzheimer’s disease clinical trials in the quest […]
William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a […]
In 2017, a patient named Anna Kuehl entered a clinical trial to test a stem cell remedy for macular degeneration. She […]